Experts are excitedly focused on retatrutide, a promising medication from Eli Lilly, as a possible step in body reduction . Different than many earlier approaches, retatrutide is a double -action agonist targeting simultaneously GLP-1 and GIP, chemicals that affect hunger and glucose balance. Pr… Read More